Beacon Pointe Advisors’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $199K | Hold |
60,000
| – | – | ﹤0.01% | 1172 |
|
|
2025
Q1 | $174K | Hold |
60,000
| – | – | ﹤0.01% | 1144 |
|
|
2024
Q4 | $214K | Hold |
60,000
| – | – | ﹤0.01% | 1115 |
|
|
2024
Q3 | $299K | Hold |
60,000
| – | – | ﹤0.01% | 1012 |
|
|
2024
Q2 | $156K | Hold |
60,000
| – | – | ﹤0.01% | 1188 |
|
|
2024
Q1 | $256K | Hold |
60,000
| – | – | ﹤0.01% | 1147 |
|
|
2023
Q4 | $121K | Hold |
60,000
| – | – | ﹤0.01% | 1247 |
|
|
2023
Q3 | $91.8K | Hold |
60,000
| – | – | ﹤0.01% | 1273 |
|
|
2023
Q2 | $99K | Buy |
+60,000
| New | +$99K | ﹤0.01% | 1041 |
|
|
2023
Q1 | – | Sell |
-60,000
| Closed | -$54.1K | – | 1143 |
|
|
2022
Q4 | $54.1K | Hold |
60,000
| – | – | ﹤0.01% | 1039 |
|
|
2022
Q3 | $70K | Hold |
60,000
| – | – | ﹤0.01% | 972 |
|
|
2022
Q2 | $38K | Buy |
+60,000
| New | +$38K | ﹤0.01% | 1028 |
|